Costello Asset Management INC Increases Holdings in JPMorgan Chase & Co.Norris Perne & French LLP MI Has $1.33 Million Stock Holdings in JPMorgan Chase & Co.(NYSE:JPM) Stake Lessened by Union Heritage Capital LLC PBMares Wealth Management LLC Sells 325 Shares of JPMorgan Chase & Co.Stoneridge Investment Partners LLC Acquires 37,150 Shares of JPMorgan Chase & Co.Strategic Wealth Investment Group LLC Grows Holdings in JPMorgan Chase & Co.Has $32.98 Million Holdings in JPMorgan Chase & Co. (NYSE:JPM) Shares Sold by Delta Capital Management LLC Gouws Capital LLC Has $303,000 Holdings in JPMorgan Chase & Co.Stratos Wealth Advisors LLC Sells 1,147 Shares of JPMorgan Chase & Co.Receive News & Ratings for ProPhase Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProPhase Labs and related companies with 's FREE daily email newsletter. 3 Grocery Stocks That Can Help Take a Bite Out of Inflation.Altria Group (NYSE MO): A Contentious High-Yield Dividend Stock.Levi Strauss Proves Resilient For Dividend Investors. AT&T (NYSE:T) Is Its Cheaper Valuation Worth A Buy?.Get a free copy of the research report on ProPhase Labs (PRPH).It offers a range of OTC dietary supplements, including Legendz XL for male sexual health and Triple Edge XL, an energy and stamina booster. The company operates in two segments, Diagnostic Services and Consumer Products. ProPhase Labs, Inc engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. 9.75% of the stock is currently owned by institutional investors. State Street Corp now owns 31,063 shares of the company’s stock worth $217,000 after buying an additional 3,868 shares during the last quarter. Finally, State Street Corp boosted its stake in shares of ProPhase Labs by 14.2% in the first quarter. now owns 512,609 shares of the company’s stock worth $3,588,000 after buying an additional 14,671 shares during the last quarter. boosted its stake in shares of ProPhase Labs by 2.9% in the first quarter. Avidian Wealth Solutions LLC now owns 140,342 shares of the company’s stock valued at $982,000 after buying an additional 20,588 shares in the last quarter. Avidian Wealth Solutions LLC increased its position in ProPhase Labs by 17.2% during the 1st quarter. The ex-dividend date was Tuesday, May 24th.Ī number of large investors have recently made changes to their positions in PRPH. Stockholders of record on Wednesday, May 25th were given a $0.30 dividend. The business also recently declared a dividend, which was paid on Friday, June 3rd. will post 0.55 EPS for the current fiscal year. As a group, equities analysts anticipate that ProPhase Labs, Inc. The company had revenue of $47.53 million during the quarter, compared to analysts’ expectations of $24.31 million. ProPhase Labs had a return on equity of 25.26% and a net margin of 15.91%. The company reported $0.68 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.39 by $0.29. ProPhase Labs ( NASDAQ:PRPH – Get Rating) last posted its quarterly earnings data on Friday, May 13th.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |